NCT04761822 2025-08-12
SARS
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
Clinical Trials
3 trialsNCT01206777 2017-12-20
Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT00929162 2012-08-07
ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer
AstraZeneca
Phase 2 Terminated